Prof. Dr. Duygu Derin

Prof. Dr. Duygu Derin
Academic Title :
Prof. Dr.

Prof. Dr. Duygu Derin is a medical oncologist at Liv Hospital Ulus in Istanbul, Turkey. She graduated from Istanbul University Istanbul Faculty of Medicine in 1993, completed her Internal Medicine specialization in 2001, and qualified in Medical Oncology in 2006. She became an Associate Professor of Medical Oncology in April 2010 and a Professor in April 2016. Her clinical interests include breast, lung, colorectal, and gynecological cancers, with experience in systemic cancer therapies and participation in clinical oncology research.

Education and Academic Qualifications

  • Graduate of Galatasaray Lycée, 1987
  • Doctor of Medicine (MD) from Istanbul University, Istanbul Faculty of Medicine, 1993
  • Specialization in Internal Medicine from Taksim Training and Research Hospital, 2001
  • Fellowship in Medical Oncology from Istanbul University Oncology Institute, 2006
  • Earned the title of Associate Professor of Medical Oncology, April 2010
  • Earned the title of Professor of Medical Oncology, April 2016

Areas of Interest

  • Breast cancer treatment in Turkey

  • Lung cancer

  • Colon and colorectal cancers

  • Medical treatment of gynecological cancers, particularly ovarian cancer

  • Chemotherapy for solid tumors

  • Hormonal and targeted therapies for breast cancer

  • Immunotherapy and other systemic cancer treatments, depending on tumor type

  • Clinical research in systemic cancer therapies

  • Medical Oncology Specialist at Liv Hospital Ulus in Istanbul (2016 - Present)
  • Medical Oncology Specialist at NeoLife Medical Center (2010 - 2016)
  • Medical Oncology Specialist at American Hospital Istanbul (2009 - 2010)
  • Mandatory Service as Oncology Specialist at Kayseri Training and Research Hospital (2006 - 2008)
  • Turkish Medical Oncology Society
  • Turkish Medical Association
  • Turkish Association for Lung Cancer
  • Galatasaray Lycée Alumni Association
  • Utility of serum and urine uPAR levels for diagnosis of breast cancer, Asian Pacific Journal of Cancer Prevention, 2012
  • Serum levels of apoptosis biomarkers, survivin and TNF-alpha in non-small cell lung cancer, Lung Cancer, 2008
  • Effect of kefir on the quality of life of patients being treated for colorectal cancer, Oncology Nursing Forum, 2009
  • Serum and urine survivin levels in breast cancer, Medical Oncology, 2006
Share :